Do you have any queries?

or Call us now at 9982-782-555

back-arrow-image Search Health Packages, Tests & More

Breast IHC Panel-ER, PR, HER2/neu (c-erb-B2), Ki-67

50+ booked in last 3 days



IHC Breast Panels (ER, PR, C-erb-B2, Ki-67) analyze protein levels in breast cancer tissue samples. These proteins, estrogen receptor (ER), progesterone receptor (PR), HER2/neu (C-erb-B2), and Ki-67, influence tumor growth and response to treatment.

Knowing their presence and levels helps doctors tailor treatment plans. For example, ER-positive tumors might benefit from hormone therapy, while HER2-positive tumors might respond well to targeted therapies. Additionally, Ki-67, a marker of cell proliferation, provides information on tumor aggressiveness. Overall, IHC Breast Panels play a crucial role in guiding personalized and effective treatment strategies for breast cancer patients.

Read More

Breast IHC Panel-ER, PR, HER2/neu (c-erb-B2), Ki-67 Price

Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Breast IHC Panel-ER, PR, HER2/neu (c-erb-B2), Ki-67 with a clear pricing structure.

The Breast IHC Panel-ER, PR, HER2/neu (c-erb-B2), Ki-67 Price in Mumbai is ₹ 6,450 .

We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.

Frequently Asked Questions

This panel measures the expression levels of specific protein markers, including ER, PR, c-erb-B2 (HER2/neu), and Ki 67 in breast tissue samples. The panel guides treatment options and assess tumor characteristics.

This test is performed for several reasons, including:

  • To diagnose breast cancer and determine its subtype
  • To assess the hormone receptor status of the tumor
  • To evaluate HER2/neu protein expression
  • To determine the proliferative index of breast cells
  • To guide treatment decisions and monitor response to therapy

This test is recommended for individuals who:

  • Have been diagnosed with breast abnormalities or suspected breast cancer
  • Require further evaluation of their hormone receptor status or HER2/neu expression
  • Need prognostic information about their breast condition
  • Are undergoing treatment for breast cancer and require monitoring of treatment response

Abnormal results of this test may indicate various conditions, including:

  • Positive hormone receptor expression, suggesting a subtype of breast cancer that may respond to hormone therapy
  • Overexpression of HER2/neu, indicating a higher-risk breast cancer that may require targeted therapy
  • High Ki 67 proliferation index, indicating an aggressive tumor with a higher likelihood of recurrence

Discuss your test results with your doctor for further evaluation and appropriate management.

  • A small sample of breast tissue is collected through a biopsy or surgery in a hospital or clinical setup.
  • The tissue sample is processed and stained.
  • The stained tissue is examined under a microscope to assess the expression levels of ER, PR, c-erb-B2, and Ki 67.
  • Provide the original histopathology report and relevant clinical and radiological details.
  • Follow any additional instructions provided by your doctor and the laboratory.
  • Molecular testing for genetic mutations in breast cancer genes (e.g., BRCA1/BRCA2)
  • Imaging tests such as mammography, ultrasound, or MRI for further evaluation of breast abnormalities
  • Additional pathology tests, such as hormone receptor testing or HER2/neu gene amplification testing

Immunohistochemistry Panel for Breast Tissue Evaluation

Breast cancer is a type of cancer that develops from cells in the breast. It is the most common cancer affecting women worldwide, though it can also occur in men.

full medical check up

Ratings & Reviews (0)

No reviews available

Why Metropolis?

Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.

We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

lab image
170+ Advanced Labs
lab image
Trusted by Leading Doctors & Hospitals
lab images
Over 2000+ Scientific Officers
reports image
Proficiency Testing for Accurate Reports

Our Blog

Take a look at some of the related content from our blog

Latest Blogs & News

View More
View all